SCHEMBL26922372

SCHEMBL26922372

CCC(CN)c1cccc(C(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 4/20 0.41
▸ HDAC4 P56524 3/20 0.41
▸ HDAC8 Q9BY41 3/20 0.41
▸ KIF11 P52732 2/20 0.41
▸ CYP3A4 P08684 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ MDM4 O15151 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MDM2 Q00987 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26922835 1.00 TAAR1 (0.41) TAAR1HDAC4HDAC8KIF11CYP3A4
SCHEMBL26922368 1.00 TAAR1 (0.41) TAAR1HDAC4HDAC8KIF11CYP3A4
SCHEMBL11073159 0.90 TAAR1 (0.45) TAAR1HDAC4HDAC8KIF11CYP3A4
SCHEMBL21610468 0.83 KIF11 (0.40) TAAR1HDAC4HDAC8KIF11CYP3A4
SCHEMBL21610470 0.83 KIF11 (0.40) TAAR1HDAC4HDAC8KIF11CYP3A4
SCHEMBL27715706 0.82 AOC3 (0.44) TAAR1TDP1HTR2AGABBR2GABBR1
SCHEMBL11084835 0.80 SLC6A3 (0.42) TAAR1HDAC4HDAC8KIF11CYP3A4
SCHEMBL26947352 0.79 AOC3 (0.44) TAAR1ALDH1A1GABBR2GABBR1NOS3
SCHEMBL5775168 0.79 IDO1 (0.42) TAAR1ALDH1A1CA1CA2MAPT
SCHEMBL9883145 0.79 SLC6A2 (0.46) TAAR1HDAC4SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4316504-A2 COMPOUNDS Spero Therapeutics, Inc. (US) 2024-02-07 — — EP disclosed
EP-3810633-B1 COMPOUNDS SPERO THERAPEUTICS INC (US) 2023-12-13 — — EP disclosed
Send feedback